2022 annual financial data
NovoCure 2022 Operating margin
NovoCure 2022 operating margin with verified reported values.
Direct answer
Operating margin was -16.64%.
Operating income was -89,523,000 USD and net income was -92,534,000 USD.
Operating cash flow was 30,788,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 537,840,000 USD
- Operating income
- -89,523,000 USD
- Net income
- -92,534,000 USD
- Operating cash flow
- 30,788,000 USD